Literature DB >> 11097117

The a- and b-wave latencies as a prognostic indicator of neovascularisation in central retinal vein occlusion.

M Moschos1, D Brouzas, M Moschou, G Theodossiadis.   

Abstract

To evaluate the prognostic value of ERG in cases of central retinal vein occlusion (CRVO) regarding the development of neovascularisation (NV), we studied 20 patients with unilateral CRVO. Half of them were allocated in the perfused group and the other 10 finally developed NV and were allocated in the non-perfused group. Flash ERG was recorded from all patients. Our findings suggest that b-wave latency is the most reliable parameter in predicting NV, followed by the a-wave latency. The b/a wave amplitude of ERG ratio does not seem to be suitable for clinical use.

Entities:  

Mesh:

Year:  1999        PMID: 11097117     DOI: 10.1023/a:1002691917441

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

1.  Electroretinography as a prognostic indicator or neovascularisation in CRVO.

Authors:  A J Morrell; D A Thompson; J M Gibson; E E Kritzinger; N Drasdo
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

2.  Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis.

Authors:  S B Kaye; S P Harding
Journal:  Arch Ophthalmol       Date:  1988-03

3.  Neovascularization in central retinal vein occlusion: electroretinographic findings.

Authors:  M A Johnson; S Marcus; M J Elman; T J McPhee
Journal:  Arch Ophthalmol       Date:  1988-03

4.  Cone ERG subnormality to red flash in central retinal vein occlusion: a predictor of ocular neovascularisation?

Authors:  M S Roy; C J Mackay; P Gouras
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture.

Authors:  A Patz
Journal:  Am J Ophthalmol       Date:  1982-12       Impact factor: 5.258

6.  Classification of central retinal vein occlusion.

Authors:  S S Hayreh
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

7.  Electroretinography in the prognosis and classification of central retinal vein occlusion.

Authors:  R Sabates; T Hirose; J W McMeel
Journal:  Arch Ophthalmol       Date:  1983-02

8.  Neovascular glaucoma following central retinal vein obstruction.

Authors:  L E Magargal; G C Brown; J J Augsburger; R K Parrish
Journal:  Ophthalmology       Date:  1981-11       Impact factor: 12.079

9.  Electroretinogram b/a wave ratio improvement in central retinal vein obstruction.

Authors:  Y Matsui; O Katsumi; H Sakaue; T Hirose
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

  9 in total
  5 in total

1.  Rod and cone a-waves in central retinal vein occlusion.

Authors:  Naoyuki Tanimoto; Tomoaki Usui; Mikio Ichibe; Mineo Takagi; Keiko Suzuki; Shigeru Hasegawa; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

2.  Morphological and electrophysiological outcome in prospective intravitreal bevacizumab treatment of macular edema secondary to central retinal vein occlusion.

Authors:  Ivana Gardašević Topčić; Maja Šuštar; Jelka Brecelj; Marko Hawlina; Polona Jaki Mekjavić
Journal:  Doc Ophthalmol       Date:  2014-06-07       Impact factor: 2.379

3.  Electroretinographic assessment of retinal function during acute exposure to normobaric hypoxia.

Authors:  Andreas Schatz; Maurice Breithaupt; Jens Hudemann; Andreas Niess; André Messias; Eberhart Zrenner; Karl Ulrich Bartz-Schmidt; Florian Gekeler; Gabriel Willmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-06       Impact factor: 3.117

4.  Continuous wavelet transform analysis of ERG in patients with diabetic retinopathy.

Authors:  Hamid Ahmadieh; Soroor Behbahani; Sare Safi
Journal:  Doc Ophthalmol       Date:  2020-11-23       Impact factor: 2.379

5.  Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat.

Authors:  João Martins; Miguel Castelo-Branco; Ana Batista; Bárbara Oliveiros; Ana Raquel Santiago; Joana Galvão; Eduarda Fernandes; Félix Carvalho; Cláudia Cavadas; António F Ambrósio
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.